Sigma Pharmaceuticals Earns QAS Accreditation

NORTH LIBERTY, Iowa - Feb. 26, 2020 - PRLog -- Sigma Pharmaceuticals, LLC ("Sigma"), a national wholesale pharmaceutical distributor specializing in ophthalmic products, announced today that it has earned Quality and Security ("QAS") Accreditation through the National Coalition for Drug Quality & Security ("NCDQS").

Wholesale drug distributors that are accredited by NCDQS are verified to have proper licensing, appropriately source, handle and secure prescription products, verify vendors and customers, and comply with state and federal regulations.  Applicants for QAS Accreditation must undergo a rigorous review of submitted data and select policies and procedures, background checks on key personnel, licensure verification, and an on-site survey to verify security, storage conditions, performance to policies and procedures, and operations.

According to Nichole Moreau, Director of Operations for Sigma, "We are excited about this accreditation because it gives our customers assurance that they are purchasing pharmaceuticals from a company that has demonstrated compliance with strict standards and is committed to protecting the quality and integrity of the drug supply chain."

About Sigma Pharmaceuticals, LLC

Sigma Pharmaceuticals, LLC is a privately held company headquartered in North Liberty, Iowa.  For over 34 years, eyecare professionals have trusted Sigma to provide them with a complete selection of ophthalmic pharmaceuticals, exam room supplies and specialty eyecare products for retail sale.  They offer extremely competitive pricing with outstanding customer service.  For more information, visit www.sigmapharmaceuticals.com.

About NCDQS

The National Coalition for Drug Quality and Security was formed in 2018 by supply chain industry members.  In addition to the Accreditation Board, NCDQS has an Advisory Board comprised of people from the industry, including those with experience in distribution, manufacturing, repackaging and relabeling, 3PLs, consultants, FDA, DEA, and Boards of Pharmacy.  The advisory board does not make decisions but provides input on the development and maintenance of standards including best practice, emerging issues in the drug supply chain, and compliance considerations.